During the past decade, University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics" #1 collaborator was "Rho Federal Systems Division, Inc." with 2 trials as a collaborator, "Autoimmunity Centers of Excellence" with 1 trials as a collaborator, "Immune Tolerance Network (ITN)" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics" are "Pulmonary Hypertension" (2 trials), "Acute Interstitial Pneumonitis" (1 trials), "Cryptogenic Organizing Pneumonia" (1 trials), "Desquamative Interstitial Pneumonia" (1 trials) and "Diffuse Cutaneous Systemic Sclerosis" (1 trials). Many other conditions were trialed in "University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics" in a lesser frequency.

Most popular intervention types in "University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics" are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bardoxolone methyl" (2 trials), "Iloprost Injection, for intravenous use" (2 trials), "Placebo" (2 trials), "Placebo IV infusion" (2 trials) and "Ad26.COV2.S" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics" are 6 trials for "All" genders.

Currently, there are NaN active trials in "University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".